in a more complete study of 8 patients longitudinally followed up for at least 20 months , a comparison of lsi with antibodies to a variety of ebv antigens including viral capsid antigen , early antigen , and nuclear antigen indicated that lsi levels provided a reliable and sensitive indicator of disease activity that should be added to clinical markers currently in use as monitors of disease activity in npc .
C0003320
antigen
C0024262
lsi